nodes	percent_of_prediction	percent_of_DWPC	metapath
Glycine—GSS—Glutathione synthesis and recycling—CNDP2—pharynx cancer	0.0646	0.148	CbGpPWpGaD
Glycine—GSS—Glutathione conjugation—CNDP2—pharynx cancer	0.0275	0.0628	CbGpPWpGaD
Glycine—SLC6A5—brainstem—pharynx cancer	0.0214	0.0381	CbGeAlD
Glycine—GLYAT—Phase II conjugation—CNDP2—pharynx cancer	0.0213	0.0487	CbGpPWpGaD
Glycine—GLYATL2—Phase II conjugation—CNDP2—pharynx cancer	0.0213	0.0487	CbGpPWpGaD
Glycine—GLYATL1—Phase II conjugation—CNDP2—pharynx cancer	0.0213	0.0487	CbGpPWpGaD
Glycine—GLYATL2—saliva-secreting gland—pharynx cancer	0.0186	0.0331	CbGeAlD
Glycine—SLC6A5—NRF2 pathway—ADH7—pharynx cancer	0.0144	0.033	CbGpPWpGaD
Glycine—SLC6A9—NRF2 pathway—ADH7—pharynx cancer	0.0144	0.033	CbGpPWpGaD
Glycine—GLYATL2—trachea—pharynx cancer	0.0144	0.0255	CbGeAlD
Glycine—SLC6A5—spinal cord—pharynx cancer	0.0133	0.0237	CbGeAlD
Glycine—GLYATL1—Biological oxidations—CNDP2—pharynx cancer	0.0125	0.0285	CbGpPWpGaD
Glycine—GLYATL2—Biological oxidations—CNDP2—pharynx cancer	0.0125	0.0285	CbGpPWpGaD
Glycine—GLYAT—Biological oxidations—CNDP2—pharynx cancer	0.0125	0.0285	CbGpPWpGaD
Glycine—GNMT—parotid gland—pharynx cancer	0.0123	0.0219	CbGeAlD
Glycine—GSS—Phase II conjugation—CNDP2—pharynx cancer	0.0122	0.028	CbGpPWpGaD
Glycine—SLC6A5—head—pharynx cancer	0.0119	0.0211	CbGeAlD
Glycine—GNMT—saliva-secreting gland—pharynx cancer	0.0118	0.021	CbGeAlD
Glycine—GATM—Amino acid and derivative metabolism—CNDP2—pharynx cancer	0.0116	0.0265	CbGpPWpGaD
Glycine—GLYATL1—Biological oxidations—ADH7—pharynx cancer	0.0113	0.0258	CbGpPWpGaD
Glycine—GLYATL2—Biological oxidations—ADH7—pharynx cancer	0.0113	0.0258	CbGpPWpGaD
Glycine—GLYAT—Biological oxidations—ADH7—pharynx cancer	0.0113	0.0258	CbGpPWpGaD
Glycine—GLRA2—brainstem—pharynx cancer	0.0113	0.02	CbGeAlD
Glycine—SHMT2—mouth—pharynx cancer	0.0106	0.0188	CbGeAlD
Glycine—SLC32A1—spinal cord—pharynx cancer	0.0105	0.0186	CbGeAlD
Glycine—GCAT—saliva-secreting gland—pharynx cancer	0.0102	0.018	CbGeAlD
Glycine—SLC6A9—spinal cord—pharynx cancer	0.0101	0.018	CbGeAlD
Glycine—GLYATL2—head—pharynx cancer	0.0101	0.0179	CbGeAlD
Glycine—GCAT—brainstem—pharynx cancer	0.00994	0.0177	CbGeAlD
Glycine—GLYATL2—Biological oxidations—ADH1B—pharynx cancer	0.00988	0.0226	CbGpPWpGaD
Glycine—GLYAT—Biological oxidations—ADH1B—pharynx cancer	0.00988	0.0226	CbGpPWpGaD
Glycine—GLYATL1—Biological oxidations—ADH1B—pharynx cancer	0.00988	0.0226	CbGpPWpGaD
Glycine—AGXT—Amino acid and derivative metabolism—CNDP2—pharynx cancer	0.00987	0.0226	CbGpPWpGaD
Glycine—GPR18—lymphoid tissue—pharynx cancer	0.0097	0.0172	CbGeAlD
Glycine—SLC32A1—head—pharynx cancer	0.0093	0.0165	CbGeAlD
Glycine—ALAS1—parotid gland—pharynx cancer	0.00929	0.0165	CbGeAlD
Glycine—GLRA3—head—pharynx cancer	0.00898	0.016	CbGeAlD
Glycine—SLC6A9—head—pharynx cancer	0.00898	0.016	CbGeAlD
Glycine—ALAS1—saliva-secreting gland—pharynx cancer	0.0089	0.0158	CbGeAlD
Glycine—GARS—parotid gland—pharynx cancer	0.00846	0.015	CbGeAlD
Glycine—AGXT2—Amino acid and derivative metabolism—CNDP2—pharynx cancer	0.00839	0.0192	CbGpPWpGaD
Glycine—GARS—saliva-secreting gland—pharynx cancer	0.0081	0.0144	CbGeAlD
Glycine—GARS—brainstem—pharynx cancer	0.00794	0.0141	CbGeAlD
Glycine—GCAT—trachea—pharynx cancer	0.00783	0.0139	CbGeAlD
Glycine—GRIN2C—brainstem—pharynx cancer	0.00781	0.0139	CbGeAlD
Glycine—GATM—brainstem—pharynx cancer	0.00754	0.0134	CbGeAlD
Glycine—SHMT2—parotid gland—pharynx cancer	0.00736	0.0131	CbGeAlD
Glycine—GCSH—head—pharynx cancer	0.00732	0.013	CbGeAlD
Glycine—GSS—mouth—pharynx cancer	0.00723	0.0128	CbGeAlD
Glycine—GSS—Biological oxidations—CNDP2—pharynx cancer	0.00716	0.0164	CbGpPWpGaD
Glycine—SHMT2—saliva-secreting gland—pharynx cancer	0.00705	0.0125	CbGeAlD
Glycine—GLRB—parotid gland—pharynx cancer	0.0069	0.0123	CbGeAlD
Glycine—ALAS1—trachea—pharynx cancer	0.00686	0.0122	CbGeAlD
Glycine—SHMT1—Amino acid and derivative metabolism—CNDP2—pharynx cancer	0.00684	0.0156	CbGpPWpGaD
Glycine—GLDC—spinal cord—pharynx cancer	0.00683	0.0121	CbGeAlD
Glycine—SHMT1—parotid gland—pharynx cancer	0.0067	0.0119	CbGeAlD
Glycine—GLRB—saliva-secreting gland—pharynx cancer	0.00661	0.0117	CbGeAlD
Glycine—GSS—Biological oxidations—ADH7—pharynx cancer	0.00647	0.0148	CbGpPWpGaD
Glycine—SHMT1—saliva-secreting gland—pharynx cancer	0.00642	0.0114	CbGeAlD
Glycine—PIPOX—spinal cord—pharynx cancer	0.00637	0.0113	CbGeAlD
Glycine—SLC6A9—lymph node—pharynx cancer	0.00629	0.0112	CbGeAlD
Glycine—GARS—trachea—pharynx cancer	0.00625	0.0111	CbGeAlD
Glycine—GLRA2—head—pharynx cancer	0.00623	0.0111	CbGeAlD
Glycine—GCAT—spinal cord—pharynx cancer	0.00618	0.011	CbGeAlD
Glycine—GLDC—head—pharynx cancer	0.00607	0.0108	CbGeAlD
Glycine—GSS—Biological oxidations—ADH1B—pharynx cancer	0.00568	0.013	CbGpPWpGaD
Glycine—PIPOX—head—pharynx cancer	0.00566	0.0101	CbGeAlD
Glycine—GCAT—head—pharynx cancer	0.0055	0.00977	CbGeAlD
Glycine—GPR18—lymph node—pharynx cancer	0.00547	0.00973	CbGeAlD
Glycine—GARS—lymphoid tissue—pharynx cancer	0.00544	0.00968	CbGeAlD
Glycine—ALAS1—spinal cord—pharynx cancer	0.00542	0.00963	CbGeAlD
Glycine—GRIN2A—brainstem—pharynx cancer	0.0054	0.00959	CbGeAlD
Glycine—SLC36A1—brainstem—pharynx cancer	0.00536	0.00953	CbGeAlD
Glycine—GCSH—lymph node—pharynx cancer	0.00513	0.00911	CbGeAlD
Glycine—GSS—parotid gland—pharynx cancer	0.00503	0.00894	CbGeAlD
Glycine—SHMT1—trachea—pharynx cancer	0.00495	0.0088	CbGeAlD
Glycine—GARS—spinal cord—pharynx cancer	0.00494	0.00877	CbGeAlD
Glycine—GSS—saliva-secreting gland—pharynx cancer	0.00482	0.00857	CbGeAlD
Glycine—ALAS1—head—pharynx cancer	0.00482	0.00856	CbGeAlD
Glycine—SHMT2—lymphoid tissue—pharynx cancer	0.00474	0.00842	CbGeAlD
Glycine—GSS—brainstem—pharynx cancer	0.00472	0.00839	CbGeAlD
Glycine—GATM—spinal cord—pharynx cancer	0.00469	0.00833	CbGeAlD
Glycine—SLC16A10—neck—pharynx cancer	0.00453	0.00804	CbGeAlD
Glycine—GARS—head—pharynx cancer	0.00439	0.0078	CbGeAlD
Glycine—GRIN2C—head—pharynx cancer	0.00432	0.00767	CbGeAlD
Glycine—SHMT1—lymphoid tissue—pharynx cancer	0.00431	0.00766	CbGeAlD
Glycine—GLDC—lymph node—pharynx cancer	0.00425	0.00755	CbGeAlD
Glycine—GATM—head—pharynx cancer	0.00416	0.0074	CbGeAlD
Glycine—GLRB—spinal cord—pharynx cancer	0.00402	0.00715	CbGeAlD
Glycine—GCAT—lymph node—pharynx cancer	0.00385	0.00684	CbGeAlD
Glycine—SHMT2—head—pharynx cancer	0.00382	0.00678	CbGeAlD
Glycine—GSS—trachea—pharynx cancer	0.00372	0.00661	CbGeAlD
Glycine—SLC16A10—parotid gland—pharynx cancer	0.00369	0.00655	CbGeAlD
Glycine—GLRB—head—pharynx cancer	0.00358	0.00636	CbGeAlD
Glycine—SHMT1—head—pharynx cancer	0.00347	0.00618	CbGeAlD
Glycine—ALAS1—lymph node—pharynx cancer	0.00337	0.006	CbGeAlD
Glycine—GRIN2A—spinal cord—pharynx cancer	0.00336	0.00596	CbGeAlD
Glycine—SLC16A10—epithelium—pharynx cancer	0.00308	0.00547	CbGeAlD
Glycine—GARS—lymph node—pharynx cancer	0.00307	0.00546	CbGeAlD
Glycine—SHMT2—Folate Metabolism—TP53—pharynx cancer	0.00305	0.00696	CbGpPWpGaD
Glycine—GRIN2A—head—pharynx cancer	0.00298	0.0053	CbGeAlD
Glycine—SLC36A1—head—pharynx cancer	0.00296	0.00527	CbGeAlD
Glycine—GSS—spinal cord—pharynx cancer	0.00294	0.00522	CbGeAlD
Glycine—GATM—lymph node—pharynx cancer	0.00292	0.00518	CbGeAlD
Glycine—ALAS2—Metabolism—CNDP2—pharynx cancer	0.00281	0.00643	CbGpPWpGaD
Glycine—SHMT2—lymph node—pharynx cancer	0.00267	0.00475	CbGeAlD
Glycine—GSS—head—pharynx cancer	0.00261	0.00464	CbGeAlD
Glycine—ALAS2—Metabolism—ADH7—pharynx cancer	0.00254	0.00581	CbGpPWpGaD
Glycine—GLRB—lymph node—pharynx cancer	0.0025	0.00445	CbGeAlD
Glycine—SHMT1—lymph node—pharynx cancer	0.00243	0.00432	CbGeAlD
Glycine—SLC16A10—lymphoid tissue—pharynx cancer	0.00237	0.00422	CbGeAlD
Glycine—ALAS2—Metabolism—ADH1B—pharynx cancer	0.00223	0.0051	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—CNDP2—pharynx cancer	0.00213	0.00487	CbGpPWpGaD
Glycine—ALAS2—Metabolism—B4GALT5—pharynx cancer	0.00213	0.00487	CbGpPWpGaD
Glycine—GLYAT—Metabolism—CNDP2—pharynx cancer	0.00213	0.00487	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—CNDP2—pharynx cancer	0.00213	0.00487	CbGpPWpGaD
Glycine—GATM—Metabolism—CNDP2—pharynx cancer	0.00213	0.00487	CbGpPWpGaD
Glycine—SLC36A1—lymph node—pharynx cancer	0.00207	0.00369	CbGeAlD
Glycine—BAAT—Metabolism—CNDP2—pharynx cancer	0.00203	0.00465	CbGpPWpGaD
Glycine—GLYAT—Metabolism—ADH7—pharynx cancer	0.00193	0.00441	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—ADH7—pharynx cancer	0.00193	0.00441	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—ADH7—pharynx cancer	0.00193	0.00441	CbGpPWpGaD
Glycine—GATM—Metabolism—ADH7—pharynx cancer	0.00193	0.00441	CbGpPWpGaD
Glycine—BAAT—Metabolism—ADH7—pharynx cancer	0.00184	0.0042	CbGpPWpGaD
Glycine—GSS—lymph node—pharynx cancer	0.00183	0.00325	CbGeAlD
Glycine—AGXT—Metabolism—CNDP2—pharynx cancer	0.00181	0.00414	CbGpPWpGaD
Glycine—SHMT1—Folate Metabolism—TP53—pharynx cancer	0.0018	0.0041	CbGpPWpGaD
Glycine—ALAS1—Metabolism—CNDP2—pharynx cancer	0.00176	0.00401	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—ADH1B—pharynx cancer	0.00169	0.00386	CbGpPWpGaD
Glycine—GATM—Metabolism—ADH1B—pharynx cancer	0.00169	0.00386	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—ADH1B—pharynx cancer	0.00169	0.00386	CbGpPWpGaD
Glycine—GLYAT—Metabolism—ADH1B—pharynx cancer	0.00169	0.00386	CbGpPWpGaD
Glycine—AGXT—Metabolism—ADH7—pharynx cancer	0.00164	0.00375	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—B4GALT5—pharynx cancer	0.00162	0.00369	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—B4GALT5—pharynx cancer	0.00162	0.00369	CbGpPWpGaD
Glycine—GATM—Metabolism—B4GALT5—pharynx cancer	0.00162	0.00369	CbGpPWpGaD
Glycine—GLYAT—Metabolism—B4GALT5—pharynx cancer	0.00162	0.00369	CbGpPWpGaD
Glycine—BAAT—Metabolism—ADH1B—pharynx cancer	0.00161	0.00369	CbGpPWpGaD
Glycine—ALAS1—Metabolism—ADH7—pharynx cancer	0.00159	0.00363	CbGpPWpGaD
Glycine—SHMT1—Validated targets of C-MYC transcriptional activation—TP53—pharynx cancer	0.00155	0.00355	CbGpPWpGaD
Glycine—AGXT2—Metabolism—CNDP2—pharynx cancer	0.00154	0.00352	CbGpPWpGaD
Glycine—BAAT—Metabolism—B4GALT5—pharynx cancer	0.00154	0.00352	CbGpPWpGaD
Glycine—AGXT—Metabolism—ADH1B—pharynx cancer	0.00144	0.00329	CbGpPWpGaD
Glycine—AGXT2—Metabolism—ADH7—pharynx cancer	0.00139	0.00319	CbGpPWpGaD
Glycine—ALAS1—Metabolism—ADH1B—pharynx cancer	0.00139	0.00318	CbGpPWpGaD
Glycine—AGXT—Metabolism—B4GALT5—pharynx cancer	0.00137	0.00314	CbGpPWpGaD
Glycine—SLC16A10—lymph node—pharynx cancer	0.00134	0.00238	CbGeAlD
Glycine—ALAS1—Metabolism—B4GALT5—pharynx cancer	0.00133	0.00304	CbGpPWpGaD
Glycine—SHMT1—Metabolism—CNDP2—pharynx cancer	0.00126	0.00287	CbGpPWpGaD
Glycine—GSS—Metabolism—CNDP2—pharynx cancer	0.00122	0.0028	CbGpPWpGaD
Glycine—AGXT2—Metabolism—ADH1B—pharynx cancer	0.00122	0.00279	CbGpPWpGaD
Glycine—GRIN2C—Alzheimers Disease—TP53—pharynx cancer	0.00122	0.00279	CbGpPWpGaD
Glycine—AGXT2—Metabolism—B4GALT5—pharynx cancer	0.00117	0.00267	CbGpPWpGaD
Glycine—SHMT1—Disease—B4GALT5—pharynx cancer	0.00114	0.0026	CbGpPWpGaD
Glycine—SHMT1—Metabolism—ADH7—pharynx cancer	0.00114	0.0026	CbGpPWpGaD
Glycine—GSS—Metabolism—ADH7—pharynx cancer	0.00111	0.00253	CbGpPWpGaD
Glycine—SHMT1—Metabolism—ADH1B—pharynx cancer	0.000996	0.00228	CbGpPWpGaD
Glycine—GSS—Metabolism—ADH1B—pharynx cancer	0.000971	0.00222	CbGpPWpGaD
Glycine—SHMT1—Metabolism—B4GALT5—pharynx cancer	0.000952	0.00218	CbGpPWpGaD
Glycine—GRIN2A—Alzheimers Disease—TP53—pharynx cancer	0.000931	0.00213	CbGpPWpGaD
Glycine—GSS—Metabolism—B4GALT5—pharynx cancer	0.000928	0.00212	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—EGFR—pharynx cancer	0.000408	0.000933	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CCND1—pharynx cancer	0.000307	0.000703	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—EGFR—pharynx cancer	0.000241	0.000551	CbGpPWpGaD
Glycine—SHMT1—Disease—EGFR—pharynx cancer	0.000203	0.000464	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—TP53—pharynx cancer	0.000202	0.000463	CbGpPWpGaD
